| Jeremy Harpley, CRNA | |
|
1201 Wakarusa Dr Ste A3, Lawrence, KS 66049-3889 | |
| (785) 856-6170 | |
| (785) 856-6171 |
| Full Name | Jeremy Harpley |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 1201 Wakarusa Dr Ste A3, Lawrence, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427340983 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 2270423 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Bass Baptist Health Center | Enid, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Of Enid Llc | 5193823631 | 7 |
News Archive
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.
The Health and Human Services Department (HHS) announced new steps Tuesday to bolster enrollment in insurance pools for sick people, which have come under fire from Republicans after falling short of their enrollment goals. The department announced that it is cutting premiums and easing eligibility criteria for the high-risk pools.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME). In 2014, the FDA granted EYLEA Breakthrough Therapy designation and Priority Review for the treatment of diabetic retinopathy in patients with DME.
"The health status of women is linked to their fundamental freedoms and empowerment," Susan Blumenthal, public health editor at the Huffington Post and former U.S. assistant surgeon general, and Jean Guo, a health policy intern at the Center for the Study of Presidency and Congress, write in the website's "Healthy Living" blog in a post marking International Women's Day, which was celebrated on Thursday.
Solcara has been helping AstraZeneca manage its interactions with the media through the use of Solcara Communications Centre.
› Verified 1 days ago
| Entity Name | Anesthesia Of Enid Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235298241 PECOS PAC ID: 5193823631 Enrollment ID: O20070607000418 |
News Archive
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.
The Health and Human Services Department (HHS) announced new steps Tuesday to bolster enrollment in insurance pools for sick people, which have come under fire from Republicans after falling short of their enrollment goals. The department announced that it is cutting premiums and easing eligibility criteria for the high-risk pools.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME). In 2014, the FDA granted EYLEA Breakthrough Therapy designation and Priority Review for the treatment of diabetic retinopathy in patients with DME.
"The health status of women is linked to their fundamental freedoms and empowerment," Susan Blumenthal, public health editor at the Huffington Post and former U.S. assistant surgeon general, and Jean Guo, a health policy intern at the Center for the Study of Presidency and Congress, write in the website's "Healthy Living" blog in a post marking International Women's Day, which was celebrated on Thursday.
Solcara has been helping AstraZeneca manage its interactions with the media through the use of Solcara Communications Centre.
› Verified 1 days ago
| Entity Name | Purple Martin Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902234057 PECOS PAC ID: 4486882834 Enrollment ID: O20140111000001 |
News Archive
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.
The Health and Human Services Department (HHS) announced new steps Tuesday to bolster enrollment in insurance pools for sick people, which have come under fire from Republicans after falling short of their enrollment goals. The department announced that it is cutting premiums and easing eligibility criteria for the high-risk pools.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME). In 2014, the FDA granted EYLEA Breakthrough Therapy designation and Priority Review for the treatment of diabetic retinopathy in patients with DME.
"The health status of women is linked to their fundamental freedoms and empowerment," Susan Blumenthal, public health editor at the Huffington Post and former U.S. assistant surgeon general, and Jean Guo, a health policy intern at the Center for the Study of Presidency and Congress, write in the website's "Healthy Living" blog in a post marking International Women's Day, which was celebrated on Thursday.
Solcara has been helping AstraZeneca manage its interactions with the media through the use of Solcara Communications Centre.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy Harpley, CRNA 1201 Wakarusa Dr Ste A3, Lawrence, KS 66049-3889 Ph: (785) 856-6170 | Jeremy Harpley, CRNA 1201 Wakarusa Dr Ste A3, Lawrence, KS 66049-3889 Ph: (785) 856-6170 |
News Archive
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.
The Health and Human Services Department (HHS) announced new steps Tuesday to bolster enrollment in insurance pools for sick people, which have come under fire from Republicans after falling short of their enrollment goals. The department announced that it is cutting premiums and easing eligibility criteria for the high-risk pools.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME). In 2014, the FDA granted EYLEA Breakthrough Therapy designation and Priority Review for the treatment of diabetic retinopathy in patients with DME.
"The health status of women is linked to their fundamental freedoms and empowerment," Susan Blumenthal, public health editor at the Huffington Post and former U.S. assistant surgeon general, and Jean Guo, a health policy intern at the Center for the Study of Presidency and Congress, write in the website's "Healthy Living" blog in a post marking International Women's Day, which was celebrated on Thursday.
Solcara has been helping AstraZeneca manage its interactions with the media through the use of Solcara Communications Centre.
› Verified 1 days ago
Nancy Whitson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 613 N 2nd St, Lawrence, KS 66044 Phone: 785-842-7026 | |
Jeffery L Herman, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 330 Arkansas St, Suite 210, Lawrence, KS 66044 Phone: 785-842-7026 Fax: 785-842-7088 | |
Mrs. Jessica M Davis, DNAP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 613 N 2nd St, Lawrence, KS 66044 Phone: 785-842-7026 Fax: 785-842-7088 | |
Michelle M Shroyer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 330 Arkansas St, Suite 210, Lawrence, KS 66044 Phone: 785-842-7026 Fax: 785-842-7088 | |
Cheryl L Soza, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 330 Arkansas St, Suite 210, Lawrence, KS 66044 Phone: 785-842-7026 Fax: 785-842-7088 | |
Jon Randall Holm, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 330 Arkansas St, Suite 210, Lawrence, KS 66044 Phone: 785-842-7026 Fax: 785-842-7088 | |
Christopher S Roberts, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 330 Arkansas St, Suite 210, Lawrence, KS 66044 Phone: 785-842-7026 |